Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-021645

Chief Executive Officer bought 10,000 shares at $8.99 ($89,900)

From the SEC's structured data for this filing

Trades in this filing

Ward Robert · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-03-23 Purchase : show line 1 in the form +10,000 $8.99 $89,900 10,000 D
Open-market purchases · 10,000 sh · avg $8.99 · $89,900
Loading xslF345X03/doc4.xml…